CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,285,734
- in 20 filings, $2.5M under 10b5-1 plans
Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-04 | Hopman Mark Chief Commercial Officer | Option exercise 10b5-1 | +656 | $5.10 | $3K | 33,940 |
| 2025-09-04 | Hopman Mark Chief Commercial Officer | Option exercise 10b5-1 | +4,093 | $5.10 | $21K | 38,033 |
| 2025-09-04 | Hopman Mark Chief Commercial Officer | Sale 10b5-1 | −6,818 | $19.97 | $136K | 31,215 |
| 2025-09-04 | Hopman Mark Chief Commercial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −656 | 66,428 | ||
| 2025-09-04 | Hopman Mark Chief Commercial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −4,093 | 33,136 | ||
| 2025-09-02 | Saint Sean President & CEO | Sale | −3,359 | $18.86 | $63K | 101,202 |
| 2025-09-02 | Russell Steven Jon Chief Medical Officer | Sale | −1,015 | $18.86 | $19K | 71,017 |
| 2025-09-02 | Mensinger Mike Chief Product Officer | Sale | −1,089 | $18.86 | $21K | 91,815 |
| 2025-09-02 | Hopman Mark Chief Commercial Officer | Sale | −848 | $18.86 | $16K | 33,284 |
| 2025-09-02 | Feider Stephen Chief Financial Officer | Sale | −1,462 | $18.86 | $28K | 44,041 |
| 2025-08-22 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +4,413 | $5.10 | $23K | 49,916 |
| 2025-08-22 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −4,413 | $17.01 | $75K | 45,503 |
| 2025-08-22 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −4,413 | 99,695 | ||
| 2025-08-19 | Hopman Mark Chief Commercial Officer | Option exercise 10b5-1 | +16,158 | $5.10 | $82K | 50,290 |
| 2025-08-19 | Hopman Mark Chief Commercial Officer | Sale 10b5-1 | −16,158 | $16.61 | $268K | 34,132 |
| 2025-08-19 | Hopman Mark Chief Commercial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −16,158 | 67,084 | ||
| 2025-08-19 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +5,587 | $5.10 | $28K | 51,090 |
| 2025-08-19 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −5,587 | $17.03 | $95K | 45,503 |
| 2025-08-19 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,587 | 104,108 | ||
| 2025-06-02 | Hopman Mark Chief Commercial Officer | Sale | −238 | $17.03 | $4K | 34,762 |
Page 7 of 11 · 210 trades